Long-term evolution of anti-HCV-positive renal transplant recipients

Transplantation Proceedings

Volumn 30, Issue 5, 1998, Pages 2076-2078

  Aroldi, A ^a   Lampertico, P ^a   Elli, A ^a   Lunghi, G ^a   Tarantino, A ^a   Montagnino, G ^a   Colombo, M ^a   Ponticelli, C ^a   Adriana, A ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; CONFERENCE PAPER; CONTROLLED STUDY; DEATH; DISEASE COURSE; HEPATITIS C; HUMAN; KIDNEY TRANSPLANTATION; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

ADULT; AZATHIOPRINE; BLOOD TRANSFUSION; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; SURVIVAL RATE; TIME FACTORS;

EID: 0031657016     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)00545-4     Document Type: Conference Paper

References (3)

1. Vosnides GG: Kidney Int 52:843, 1997
2. Roth D, Zucker K, Cirocco R, et al: Kidney Int 45:238, 1994
3. Pereira BJG, Wright TL, Schmid, et al: Transplantation 60:799, 1995